Skip to main content
Year archive

Immunovia — 2023 filings

All 47 regulatory filings released by Immunovia (IMMNOV) in 2023, sourced directly from the official regulator.

47 Filings
2023 Period
2023 filings (47)
Filing Released Lang
Bulletin from the extraordinary general meeting in Immunovia AB
Declaration of Voting Results & Voting Rights Announcements
2023-11-21 English
Kommuniké från extra bolagsstämma i Immunovia AB
AGM Information
2023-11-21 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-09 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-09 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IMMUNOVIA AB (PUBL)
Proxy Solicitation & Information Statement
2023-10-27 Swedish
CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)
AGM Information
2023-10-27 English
Valberedning utsedd i Immunovia AB (Publ)
AGM Information
2023-10-03 Swedish
Nomination Committee appointed for Immunovia AB (Publ)
Board/Management Information
2023-10-03 English
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-08-30 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-08-30 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-08-29 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-28 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-22 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-01 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-07-25 English
Immunovia omstrukturerar väsentligt för att fokusera resurser på nästa generations blodtest för upptäckt av pankreascancer
Regulatory Filings
2023-07-11 Swedish
Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection
Regulatory Filings
2023-07-11 English
Change in number of shares and votes in Immunovia AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-05-31 English
Förändring av antal aktier och röster i Immunovia AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-05-31 Swedish
Bulletin from the Annual General Meeting in Immunovia AB
AGM Information
2023-05-26 English
Kommuniké från årsstämma i Immunovia AB
AGM Information
2023-05-26 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-23 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-23 English
Changes to the Nomination Committee's proposal to the Annual General Meeting 2023 in Immunovia AB (publ)
Board/Management Information
2023-05-22 English
Ändringar av valberedningens förslag till årsstämman 2023 i Immunovia AB (publ)
AGM Information
2023-05-22 Swedish
Styrelseledamoten Philipp von Hugo lämnar Immunovias styrelse på egen begäran
Board/Management Information
2023-05-06 Swedish
The board member Philipp von Hugo resigns from Immunovia's board at his own request
Board/Management Information
2023-05-06 English
Immunovia AB appoints new CEO
Board/Management Information
2023-04-29 English
Immunovia AB utser ny VD
Board/Management Information
2023-04-29 Swedish
KALLELSE TILL ÅRSSTÄMMA I IMMUNOVIA AB
AGM Information
2023-04-25 Swedish
CONVENING NOTICE - ANNUAL GENERAL MEETING IN IMMUNOVIA AB (publ)
AGM Information
2023-04-25 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-04-21 Swedish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-04-19 English
Immunovia announces outcome of the rights issue
Capital/Financing Update
2023-04-12 English
Immunovia offentliggör utfall i företrädesemissionen
Capital/Financing Update
2023-04-12 Swedish
Immunovia offentliggör prospekt i samband med företrädesemissionen
Report Publication Announcement
2023-03-17 Swedish
Immunovia publishes prospectus relating to the rights issue
Capital/Financing Update
2023-03-17 English
Bulletin from the extraordinary general meeting in Immunovia AB
Capital/Financing Update
2023-03-16 English
Kommuniké från extra bolagsstämma i Immunovia AB
AGM Information
2023-03-16 Swedish
Immunovia appoints Karl Stone as new chief operating officer to develop R&D and operations
Board/Management Information
2023-03-01 English
Immunovia utser Karl Stone till ny COO för att utveckla FoU-verksamheten
Board/Management Information
2023-03-01 Swedish
Earnings Release 2022
Earnings Release Q4 2022
2023-02-23 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q4 2022
2023-02-23 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IMMUNOVIA AB
AGM Information
2023-02-20 Swedish
CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (publ)
AGM Information
2023-02-20 English
Immunovia resolves on a rights issue of approximately SEK 202.2 million and postpones the publication of the quarterly report for the first quarter and the annual general meeting
Share Issue/Capital Change
2023-02-20 English
Immunovia beslutar om en företrädesemission om cirka 202,2 miljoner SEK och senarelägger offentliggörandet av kvartalsrapport för det första kvartalet och årsstämman
Share Issue/Capital Change
2023-02-20 Swedish